0001567619-21-008995.txt : 20210504 0001567619-21-008995.hdr.sgml : 20210504 20210504165516 ACCESSION NUMBER: 0001567619-21-008995 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20210430 FILED AS OF DATE: 20210504 DATE AS OF CHANGE: 20210504 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Adams Gabrielle B. CENTRAL INDEX KEY: 0001651089 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-10670 FILM NUMBER: 21889470 MAIL ADDRESS: STREET 1: 10910 DOMAIN DRIVE, SUITE 300 CITY: AUSTIN STATE: TX ZIP: 78758 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: HANGER, INC. CENTRAL INDEX KEY: 0000722723 STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-SPECIALTY OUTPATIENT FACILITIES, NEC [8093] IRS NUMBER: 840904275 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 10910 DOMAIN DRIVE STREET 2: SUITE 300 CITY: AUSTIN STATE: TX ZIP: 78758 BUSINESS PHONE: 512-777-3800 MAIL ADDRESS: STREET 1: 10910 DOMAIN DRIVE STREET 2: SUITE 300 CITY: AUSTIN STATE: TX ZIP: 78758 FORMER COMPANY: FORMER CONFORMED NAME: HANGER ORTHOPEDIC GROUP INC DATE OF NAME CHANGE: 19920703 FORMER COMPANY: FORMER CONFORMED NAME: SEQUEL CORP DATE OF NAME CHANGE: 19890814 FORMER COMPANY: FORMER CONFORMED NAME: CELLTECH COMMUNICATIONS INC DATE OF NAME CHANGE: 19860304 4 1 doc1.xml FORM 4 X0306 4 2021-04-30 0 0000722723 HANGER, INC. HGR 0001651089 Adams Gabrielle B. 10910 DOMAIN DRIVE, SUITE 300 AUSTIN TX 78758 0 1 0 0 Vice President Accounting Common Stock 2021-04-30 4 M 0 20938 12.77 A 80961 D Common Stock 2021-04-30 4 S 0 20938 25.0257 D 60023 D Stock Options (right to buy) 12.77 2021-04-30 4 M 0 20938 0 D 2027-05-19 Common Stock 20938 0 D The transaction by Ms. Adams was effected automatically upon the satisfaction of certain timing, trading price and other conditions under a trading plan designed to comply with Rule 10b5-1 of the Securities Exchange Act of 1934. Ms. Adams entered into this trading plan on March 8, 2021 and additional periodic sales may occur under this plan through the end of 2021 if the conditions of the plan are met. These shares were sold at a range of sale prices from $25.00 to $25.10. The reporting person will provide upon request by the Commission staff, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price. Includes (i) unvested restricted shares totaling 4,227 shares of stock from an initial grant of 4,227 shares of restricted stock that begins to vest on March 8, 2022;(ii) unvested restricted shares totaling 3,230 shares of stock from an initial grant of 3,583 shares of restricted stock that begins to vest on March 9, 2021; (iii) unvested restricted shares totaling 3,800 shares of stock from an initial grant of 4,215 shares of restricted stock that begins to vest on March 9, 2021; (iv) unvested restricted shares and fully vested shares totaling 3,095 shares of stock from an initial grant of 3,854 shares of restricted stock made on March 8, 2019; (v) unvested restricted shares and fully vested shares totaling 3,668 shares of stock from an initial grant of 4,567 shares of restricted stock made on March 8, 2019; [continued in next footnote] (vi) unvested restricted shares and fully vested shares totaling 3,180 shares of stock from an initial grant of 4,435 shares of restricted stock made on March 8, 2019; (vii) unvested restricted shares and fully vested shares totaling 3,997 shares of stock from an initial grant of 5,574 shares of restricted stock made on March 9, 2018; (viii) unvested restricted shares and fully vested shares totaling 5,710 shares of stock from an initial grant of 7,950 shares of restricted stock made on March 8, 2017; [continued in next footnote] (ix) fully vested shares totaling 2,446 shares of stock from an initial grant of 3,000 shares of restricted stock made on October 11, 2016; (x) unvested restricted shares and fully vested shares totaling 6,233 shares of stock from an initial grant of 7,750 shares of restricted stock made on April 29, 2016; (xi) fully vested shares which total 3,020 shares of stock from an initial grant of 3,305 shares of restricted stock made on November 10, 2015; [continued in next footnote] (xii) fully vested shares which total 2,037 shares of stock from an initial grant of 2,229 shares of restricted stock made on September 8, 2015; and (xiii) fully vested shares which total 3,818 shares of stock from an initial grant of 4,239 shares of restricted stock made on March 6, 2015. Except as otherwise noted, all remaining unvested restricted shares will continue to vest at a rate of 25% per year of the original grant amount on the anniversary date of the grant. Stock options were granted under the Company's Special Equity Plan and vest 1/3 on each of May 19, 2018, 2019 and 2020. Jessica Lochmann Allen, Attorney-in-Fact for Gabrielle B. Adams 2021-05-04